K
Kevin Kumar Vijayakumar
Researcher at Madurai Kamaraj University
Publications - 8
Citations - 46
Kevin Kumar Vijayakumar is an academic researcher from Madurai Kamaraj University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 5 publications receiving 19 citations.
Papers
More filters
Journal ArticleDOI
Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds.
Konda Mani Saravanan,Haiping Zhang,Renganathan Senthil,Kevin Kumar Vijayakumar,Vignesh Sounderrajan,Yanjie Wei,Harshavardhan Shakila +6 more
TL;DR: It is insisted that the amentoflavone, hypericin and Torvoside H from the traditional Indian medicinal plants may be used as a potential inhibitor of SARS-CoV2 main protease and further biochemical experiments could shed light on understanding the mechanism of inhibition by these plant-derived antiviral compounds.
OtherDOI
Electrochemical Immunosensors: Working Principle, Types, Scope, Applications, and Future Prospects
Shakila Harshavardhan,Sam Ebenezer Rajadas,Kevin Kumar Vijayakumar,Willsingh Anbu Durai,Andy Ramu,Rajan Mariappan +5 more
Book ChapterDOI
Basics of tuberculosis disease and principles of treatment and their effects
Shakila Harshavardhan,Kevin Kumar Vijayakumar,Vignesh Sounderrajan,Pushparaju Ramasamy,Sam Ebenezer Rajadas +4 more
TL;DR: In this paper, the authors developed the Directly Observed Treatment, Short-Course (DOTS) protocol for TB, which involves an antiregimen with four drugs: isoniazid (H), rifampin (R), pyrazinamide (Z), and either ethambutol (E) or streptomycin (S) for 2 months.
Journal ArticleDOI
Emerging role of exosomes in hematological malignancies
Sureshbabu Ram Kumar Pandian,Kevin Kumar Vijayakumar,Selvaraj Kunjiappan,Ewa Babkiewicz,Piotr Maszczyk +4 more
TL;DR: This review is focused on the source, composition, function and surface engineering of exosomes pertaining to hematological malignancies, and repurposing small vesicles for myeloma therapy.
Journal ArticleDOI
Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases
Sureshbabu Ram Kumar Pandian,Kevin Kumar Vijayakumar,Sankaranarayanan Murugesan,Selvaraj Kunjiappan +3 more
TL;DR: In this article , a review of the characteristics, surface functionalization, drug loading, and biodistribution of liposomes respective to Alzheimer's disease and Parkinson's disease is presented.